Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.01% | 176.96 | 0.7% | $1383.16m | |
| MRK | Merck & Co., Inc. | 0.66% | 92.50 | 0.7% | $1203.71m | |
| PFE | Pfizer Inc. | 0.55% | 50.94 | 0.9% | $1160.82m | |
| LLY | Eli Lilly & Co. | 1.74% | 323.14 | 1.1% | $1096.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 78.28 | 1.0% | $1078.11m | |
| ABBV | AbbVie, Inc. | 0.96% | 153.95 | 1.9% | $992.07m | |
| AZN | AstraZeneca Plc | 1.65% | 67.02 | 1.0% | $451.24m | |
| SGEN | Seagen Inc. | 0.33% | 179.06 | 5.7% | $322.85m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.32% | 75.30 | 0.0% | $286.13m | |
| GSK | GSK Plc | 0.97% | 43.77 | 0.2% | $281.98m | |
| HZNP | Horizon Therapeutics Plc | 0.99% | 82.50 | 5.4% | $176.10m | |
| NVS | Novartis AG | 0.70% | 84.76 | 0.2% | $166.17m | |
| MRTX | Mirati Therapeutics, Inc. | -1.84% | 67.24 | 1.6% | $154.95m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.85% | 145.64 | 0.0% | $148.67m | |
| NVO | Novo Nordisk A/S | 1.63% | 110.06 | 0.1% | $146.95m |
Company Profile
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The firm product TARPEYO is used to reduce proteinuria in adults with primary immunoglobulin. The company was founded by Mikael Bender and Bengt Ã…ke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.